A Delaware judge has dismissed a request from GSK Plc (NYSE:GSK) and other pharmaceutical companies to appeal a ruling that allows over 70,000 lawsuits alleging the heartburn drug Zantac causes cancer ...

Aug 27 (Reuters) - Delaware's highest court said on Tuesday it will hear an appeal by GSK (GSK.L), opens new tab and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued ...

The Food and Drug Administration announced that the popular heartburn medication Zantac, or ranitidine, and some generic versions of the medication, could have an impurity that could cause cancer. The ...

(Reuters) - A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.

A federal court in Florida has dismissed all claims—without leave to amend—against all generic ranitidine and store-brand manufacturers in the multidistrict litigation over the heartburn medication ...

Aug 16 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Friday it would seek a dismissal of an upcoming Zantac case in Florida, where plaintiffs alleged that its discontinued heart ...

WASHINGTON -- U.S. health officials said Friday they are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related generic drugs. For now, ...

Drugmaker Sanofi announced on Friday a voluntary recall of the heartburn drug Zantac from all stores in the United States and Canada amid investigations into the presence of a carcinogen discovered in ...

Cancer affects roughly one in three women and one in three men in the United States, and last year, there were an estimated 1,762,450 new cases of cancer reported on record. While the types of cancer ...

The U.S. Food and Drug Administration announced Wednesday it is requesting manufacturers remove all prescription and over-the-counter ranitidine drugs from the market immediately. This is the latest ...